Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
VeroXEN by Microgen for Tick Borne Encephalitis: Likelihood of Approval
VeroXEN is under clinical development by Microgen and currently in Phase I for Tick Borne Encephalitis. According to GlobalData, Phase...